| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/27/2004 | US20040101929 Comprises transgenic yellow grouper brain cell expressing immunoglobulin complex which prevents viral infection in teleost farms; animal husbandry and veterinary medicine |
| 05/27/2004 | US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101855 Modulation of PPAR binding protein expression |
| 05/27/2004 | US20040101854 Modulation of BCL2-associated athanogene expression |
| 05/27/2004 | US20040101853 Modulation of STAT2 expression |
| 05/27/2004 | US20040101852 Antisense nucleotide sequences for treatment of neurodegenerative diseases |
| 05/27/2004 | US20040101825 Comprises expression vector coding hypoxia inducible factors, regulatory elements and antitumor agents for transformation and destruction of tumor cells |
| 05/27/2004 | US20040101537 Mixture of oligonucleotide and fine particles of biodegradation polymer; concurrent administering of protein antigen |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101522 Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo |
| 05/27/2004 | US20040101514 High transgene expression of a pseudotyped adeno-associated virus type |
| 05/27/2004 | US20040101512 Adenoviral vectors for treating disease |
| 05/27/2004 | CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | CA2505394A1 Human stem cell materials and methods |
| 05/27/2004 | CA2505090A1 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504701A1 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504605A1 Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| 05/27/2004 | CA2504554A1 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | CA2502890A1 Treating carcinoid neoplasms with therapeutic viruses |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421221A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421199A2 Compositions and methods for treating neurodegenerative diseases |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421170A2 Therapeutic delivery compositions and methods of use thereof |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1420828A2 Lipophilic drug compositions |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420803A1 Method for amplifying expression from a cell specific promoter |
| 05/26/2004 | EP1420801A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420769A2 Lipid profile modulation with steroids |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1150705B1 Protection of cells with bbi in connection with treatment with chemical agents |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1498968A Constructing targeted carrier used in gene therapy for cancer and usage |
| 05/26/2004 | CN1498964A Serial recombined gland related virus inducible path of RNAi, and utilized in gene therapy |
| 05/25/2004 | US6740750 Ribozyme sequences related to hiv resistance |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740659 Treatment of dyskinesia |
| 05/25/2004 | US6740643 Compositions and methods for drug delivery using amphiphile binding molecules |
| 05/25/2004 | US6740525 Adenoviral capsid containing chimeric protein IX |
| 05/25/2004 | US6740524 A phage expressing a bi-functional protein with a nuclear translocation and cell adhesion activities; used to package a foreign substance such as a gene, and in gene therapy |
| 05/25/2004 | US6740523 Administering 14-3-3 sigma protein for suppressing growth of tumor cells |
| 05/25/2004 | US6740515 Recombinant adenovirus |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740511 Comprising mutations at one or more residues within the region of fiber stretching; used in gene therapy |
| 05/25/2004 | US6740503 By illegitimate recombination of a regulatory sequence; identification, activation, isolation, and/or expression of genes without need for target sequence during integration |
| 05/25/2004 | US6740336 Process for generating multilayered particles |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/25/2004 | CA2342283C Recombinant adenovirus for tissue specific expression in heart |
| 05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 05/21/2004 | WO2004042061A1 Pharmaceutical composition for suppressing undesired gene expression |
| 05/21/2004 | WO2004042027A2 Allele-specific rna interference |
| 05/21/2004 | WO2004042025A2 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 05/21/2004 | WO2004041924A2 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/21/2004 | WO2004041889A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | WO2004041843A2 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 05/21/2004 | WO2004041778A2 A method for increasing synaptic growth or plasticity |
| 05/21/2004 | WO2004041301A1 Antidiuretics |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041200A2 Dna based plasmid formulations and vaccines and prophylactics containing the same |
| 05/21/2004 | WO2004041197A2 Methods of inhibiting glial scar formation |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041183A2 Methods of treating pulmonary fibrotic disorders |
| 05/21/2004 | WO2004041065A2 METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| 05/21/2004 | WO2004027049A3 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 05/21/2004 | WO2004024087A9 Methods of diagnosing and treating hyperproliferative disorders |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004009824A3 Pav regions for encapsidation and e1 transcriptioonal control |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003078595B1 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response |
| 05/21/2004 | WO2003077796A3 Ophthalmic solutions for delivery of expression vectors |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003066650A3 Short interfering rna molecules directed towards a tissue factor coding nucleic acid |
| 05/21/2004 | WO2003050249B1 Islet cells from human embryonic stem cells |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |